Reports for RANBAXY PHARMACEUTICALS CANADA INC.
Company Name
RANBAXY PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
72 |
|
| Actual shortage: | 4 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 68 (94%) | |
Discontinuation Reports |
32 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 32 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
47 (45%) |
|
Overdue reports |
4 (100%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-EZETIMIBE | 10MG | TABLET | Resolved | 2020-01-20 | 2020-03-07 | 103675 |
| RAN-EZETIMIBE | 10MG | TABLET | Resolved | 2022-01-06 | 2022-02-15 | 152160 |
| RAN-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2017-05-24 | 2019-02-01 | 11167 |
| RAN-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2017-05-24 | 2019-02-01 | 11133 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-22 | 2018-08-21 | 30228 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-05-31 | 2019-09-09 | 85347 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-27 | 2019-02-04 | 27316 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-20 | 2020-02-02 | 103678 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-16 | 2019-02-01 | 36060 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-02-02 | 2020-03-07 | 105127 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-16 | 2019-02-01 | 36063 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-05-31 | 2019-08-19 | 85342 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|